Skip to content

Protection Motivation Theory-Based Education for Infectious Disease Prevention in Primary Care

The Effect of Protection Motivation Theory-Based Education on Infectious Disease Perception, Risk Awareness, and Protective Health Behaviors in Primary Care

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07790367
Acronym
PMT-ID
Enrollment
200
Registered
2026-08-27
Start date
2026-09-01
Completion date
2026-11-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious Disease Prevention

Keywords

Protection Motivation Theory, Infectious Diseases, Risk Awareness, Protective Health Behaviors, Health Education, Primary Health Care

Brief summary

This study aims to evaluate the effect of a Protection Motivation Theory-based educational intervention on infectious disease perception, risk awareness, and protective health behaviors among adults attending primary care services. Participants will be assigned to an intervention group or a control group. The intervention group will receive a face-to-face educational program based on Protection Motivation Theory, while the control group will continue to receive routine health services without an additional educational intervention during the study period. Outcomes will be assessed at baseline and at Week 4 using validated self-report measures.

Detailed description

This study is a controlled quasi-experimental study with a pretest-posttest design. It will be conducted among adults attending a primary care center. The study is designed to evaluate whether an educational intervention based on Protection Motivation Theory can improve participants' perceptions of infectious diseases, awareness of infectious disease risks, and protective health behaviors. Participants will be allocated to an intervention group and a control group. Before the intervention, participants in both groups will complete baseline assessments. Participants in the intervention group will then receive a face-to-face educational program based on Protection Motivation Theory. The educational content will address routes of infectious disease transmission, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. Participants in the control group will not receive the educational intervention during the study period and will continue to receive routine health services. At Week 4, participants in both groups will complete the post-intervention assessments. Changes in infectious disease perception, risk awareness, and protective health behaviors will be evaluated by comparing pre-intervention and post-intervention measurements between and within the groups.

Interventions

BEHAVIORALProtection Motivation Theory-Based Educational Program

Participants in the intervention group will receive a face-to-face educational program based on Protection Motivation Theory. The program will cover infectious disease transmission routes, prevention methods, hand hygiene, mask use, environmental hygiene, maintenance of immunity, risk awareness, and protective health behaviors. The intervention is designed to enhance threat appraisal and coping appraisal related to infectious disease prevention and to promote protective health behaviors.

Sponsors

Yuzuncu Yil University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Participants will be assigned to two parallel groups: an intervention group receiving a Protection Motivation Theory-based educational program and a control group receiving routine health services without the additional educational intervention during the study period. Outcomes will be assessed at baseline and at Week 4.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Being 18 years of age or older. * Being registered with and receiving services from the family health center where the study is conducted. * Being able to communicate in Turkish. * Voluntarily agreeing to participate in the study. * Being able to complete the study questionnaires and participate in the educational intervention.

Exclusion criteria

* Having a condition that prevents effective communication or participation in the educational intervention. * Declining to participate or withdrawing consent at any stage of the study. * Failing to complete the required pre-intervention or post-intervention assessments.

Design outcomes

Primary

MeasureTime frameDescription
Change in Communicable Diseases Risk Awareness and ProtectionBaseline and Week 4Communicable disease risk awareness and protection will be assessed using the Communicable Diseases Risk Awareness and Protection Scale (CDRAPS). The scale consists of 36 items rated on a 5-point Likert scale, with total scores ranging from 36 to 180. Higher scores indicate higher levels of communicable disease risk awareness and protection. Change in total score from baseline to Week 4 will be evaluated.
Change in Perception Toward Infectious DiseasesBaseline and Week 4Perception toward infectious diseases will be assessed using the Perception Scale for Infectious Diseases. The scale consists of 34 items rated on a 5-point Likert scale, with total scores ranging from 34 to 170. Higher scores indicate a more positive perception toward infectious diseases. Change in total score from baseline to Week 4 will be evaluated.
Change in Preventive Health Behaviors for Emerging Infectious DiseasesBaseline and Week 4Preventive health behaviors will be assessed using the Turkish version of the Emerging Infectious Diseases Preventive Health Behavior Scale (EID-PHB-T-30). The scale consists of 30 items rated on a 5-point Likert scale, with total scores ranging from 30 to 150. Higher scores indicate higher levels of preventive health behaviors against emerging infectious diseases. Change in total score from baseline to Week 4 will be evaluated.

Countries

Turkey (Türkiye)

Contacts

CONTACTMuhammet Faruk Yiğit, PhD
muhammetfarukyigit@yyu.edu.tr+90 542 424 76 29
PRINCIPAL_INVESTIGATORMuhammet Faruk Yigit, PhD

Yuzuncu Yil University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026